AGIO Agios Pharmaceuticals, Inc. - Common Stock
Acerca de Agios Pharmaceuticals, Inc. - Common Stock Descripción general de la empresa de Wikipedia
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Leer más
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 (or 2007) by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
History
In 2012, Agios was named among the defendants in a lawsuit against one of its founders, Craig Thompson, alleging that Thompson used research illegally taken from the Abramson Family Cancer Research Institute in research at Agios.
In May 2016, the company announced it would launch partnership with Celgene, developing metabolic immuno-oncology therapies and licensing AG-221 as well as AG-881 to Celgene, potentially garnering Agios $120 million in drug licensing payments.
In April 2017, the company raised $250 million in a new stock offering in anticipation of approval for its first cancer drug, enasidenib, by the US Food and Drug Administration.
In December 2017, the company filed a New Drug Application with the US FDA for ivosidenib for the treatment of adult patients with relapsed or refractory acute myeloid leukemia with an IDH1 mutation.
In November 2019, Agios announced an underwritten public offering of 8,250,000 shares of common stock at a price of $31.00 per share which would result in approximately $256 million aggregate gross proceeds.
In April 2022, the FDA approved mitapivat as first disease-modifying therapy for hemolytic anemia in adults with pyruvate kinase deficiency.
Corporate governance
As of August 2022, Agios' CEO is Brian Goff.
Agios was established as a private company and converted to a public company with its initial public offering in July 2013 and subsequent listing on NASDAQ.
== References ==
Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗
AGIO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
AGIO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
AGIO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
- Compra fuerte 5 31,2%
- Compra 7 43,8%
- Mantener 4 25,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
8 analistas · 2026-08-16Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-1.69 | $-1.70 | 0.01% |
| 31 de marzo de 2026 | $-1.69 | $-1.84 | 0.15% |
| 31 de diciembre de 2025 | $-1.86 | $-1.99 | 0.13% |
| 30 de septiembre de 2025 | $-1.78 | $-1.94 | 0.16% |
| 30 de junio de 2025 | $-1.93 | $-1.84 | -0.09% |
| 31 de marzo de 2025 | $-1.55 | $-1.82 | 0.27% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| ADMA | $4.34B | 30.4 | 19.6% | 28.8% | 33.6% | 57.4% |
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| GENB | — | — | — | — | — | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Cost of Revenue | $6M | $4M | $3M | $2M | $0 | $0 | $1M | $1M | $0 | $0 | · | · | |
| R&D Expense | $340M | $301M | $296M | $280M | $257M | $221M | $214M | $341M | $293M | $220M | $142M | $100M | |
| SG&A Expense | $180M | $157M | $120M | $122M | $121M | $115M | $102M | $114M | $71M | $51M | $36M | $19M | |
| Operating Expenses | $526M | $462M | $418M | $403M | $378M | $336M | $316M | $457M | $364M | $271M | $178M | $119M | |
| Operating Income | $-472M | $-426M | $-391M | $-389M | $-378M | $-336M | $-316M | $-362M | $-321M | $-201M | $-119M | $-54M | |
| Interest Income | · | · | · | $13M | $836.0K | $7M | $15M | $16M | $6M | $3M | $968.0K | $203.0K | |
| Other Non-op | $2M | $6M | $6M | $7M | $14M | $0 | $0 | · | · | · | · | · | |
| Pretax Income | $-414M | $718M | $-352M | $-232M | $-357M | $-329M | $-301M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Income Tax | $-1M | $44M | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $-426.0K | |
| Net Income | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| EPS (Basic) | $-7.12 | $11.86 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| EPS (Diluted) | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 | $-4.74 | $-6.86 | · | · | · | · | · | |
| Shares (Basic) | 57,972,004 | 56,807,415 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| Shares (Diluted) | 57,972,004 | 57,889,255 | 55,651,487 | 54,789,435 | 60,447,346 | 68,997,879 | 59,994,539 | · | · | · | · | · | |
| EBITDA | $-472M | $-426M | $-391M | $-389M | $-378M | $-316M | $-418M | $-362M | $-321M | $-201M | $-119M | $-54M |
Balance general 22
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $76M | $88M | $139M | $203M | $127M | $81M | $71M | $103M | $161M | $72M | $14M | |
| Short-term Investments | · | · | · | · | · | · | · | $515M | $321M | $381M | · | · | |
| Inventory | $33M | $28M | $19M | $8M | $0 | $15M | $7M | $869.0K | $0 | · | · | · | |
| Prepaid Expense | $44M | $40M | $35M | $39M | $40M | $16M | $24M | $17M | $18M | $10M | $9M | $5M | |
| Current Assets | $942M | $966M | $834M | $833M | $1.06B | $637M | $612M | $614M | $445M | $560M | $337M | $360M | |
| PP&E (Net) | $11M | $12M | $15M | $23M | $29M | $31M | $31M | $24M | $24M | $25M | $23M | $6M | |
| PP&E (Gross) | $71M | $68M | $68M | $73M | $74M | $72M | $64M | $50M | $44M | $39M | $31M | $12M | |
| Accum. Depreciation | $60M | $56M | $52M | $50M | $45M | $41M | $32M | $26M | $19M | $13M | $8M | $6M | |
| Other Non-current Assets | $4M | $5M | $4M | $4M | $3M | $0 | $0 | $238.0K | $891.0K | $2M | $611.0K | $590.0K | |
| Total Assets | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Accounts Payable | $18M | $17M | $10M | $19M | $17M | $18M | $22M | $18M | $23M | $17M | $15M | $11M | |
| Accrued Liabilities | $45M | $47M | $43M | $30M | $32M | $31M | $53M | $42M | $34M | $32M | $16M | $14M | |
| Current Liabilities | $82M | $81M | $68M | $63M | $60M | $94M | $93M | $94M | $95M | $88M | $53M | $61M | |
| Capital Leases | $22M | $40M | $57M | $72M | $86M | $97M | $106M | · | · | · | · | · | |
| Other Non-current Liabilities | $90.0K | $880.0K | $1M | $3M | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $104M | $122M | $126M | $138M | $146M | $453M | $250M | $171M | $239M | $261M | · | · | |
| Common Stock | · | · | · | · | $71.0K | $69.0K | $68.0K | $58.0K | $49.0K | $42.0K | $38.0K | $37.0K | |
| Retained Earnings | $-562M | $-149M | $-823M | $-471M | $-239M | $-1.84B | $-1.52B | $-1.10B | $-798M | $-483M | $-285M | $-167M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $0 | · | · | · | · | · | · | |
| Stockholders' Equity | $1.19B | $1.54B | $811M | $1.10B | $1.29B | $400M | $641M | $688M | $376M | $359M | $345M | $424M | |
| Liabilities + Equity | $1.30B | $1.66B | $937M | $1.24B | $1.44B | $853M | $891M | $858M | $614M | $619M | $420M | $492M | |
| Shares Outstanding | 58,448,592 | 73,372,696,000 | 72,161,489 | 71,256,118 | 70,550,631 | 69,293,920 | 68,401,105 | 58,218,653 | 48,826,153 | 42,220,444 | 37,696,502 | 37,100,513 |
Flujo de Efectivo 13
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $8M | $7M | $6M | · | · | · | |
| Stock-based Comp | $53M | $43M | $45M | $49M | $54M | $62M | $58M | $73M | $48M | $42M | $32M | $12M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | · | · | · | $-40M | · | · | · | · | · | |
| Operating Cash Flow | $-373M | $-390M | $-296M | $-309M | $-407M | $-291M | $-371M | $-304M | $-285M | $39M | $-77M | $-59M | |
| CapEx | $4M | $2M | $999.0K | $5M | $6M | $14M | $12M | $7M | $5M | $10M | $20M | $2M | |
| Investing Cash Flow | $377M | $363M | $240M | $243M | $1.25B | $76M | $91M | $-274M | $-58M | $-119M | $128M | · | |
| Stock Issued | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | $0 | $334M | |
| Net Stock Activity | · | · | · | · | $0 | $0 | $277M | $516M | $270M | $162M | · | $334M | |
| Financing Cash Flow | $9M | $14M | $5M | $2M | $-766M | $262M | $290M | $546M | $285M | $170M | $6M | · | |
| Net Change in Cash | $13M | $-12M | $-51M | $-64M | $76M | $47M | $10M | $-32M | $-58M | $89M | $58M | $-58M | |
| Taxes Paid | $628.0K | $43M | $2M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-377M | $-392M | $-297M | $-314M | $-413M | $-306M | $-383M | $-311M | $-290M | $29M | $-97M | $-62M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -361.6% | · | -745.8% | · | · | -82.8% | |
| Net Margin | -764.0% | 1845.9% | -1312.6% | -1627.8% | · | -161.1% | -349.0% | · | -731.6% | · | · | -81.9% | |
| Pretax Margin | -765.9% | 1967.2% | -1312.6% | -1627.8% | · | -161.2% | -349.0% | · | -731.6% | · | · | -82.5% | |
| EBITDA Margin | -873.9% | -1166.5% | -1459.5% | -2732.1% | · | -155.6% | -354.7% | · | -745.8% | · | · | -82.8% | |
| ROA | -27.9% | 51.8% | -32.4% | -17.3% | 140.1% | -37.5% | -47.0% | -47.0% | -51.0% | -38.2% | -25.8% | -15.4% | |
| ROE | -32.2% | 42.5% | -41.5% | -21.6% | 119.4% | -74.4% | -75.6% | -47.8% | -85.7% | -56.4% | -30.6% | -19.2% | |
| ROIC | -39.5% | -25.9% | · | · | · | · | -66.6% | -52.7% | -85.4% | · | · | -12.7% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 | 6.7 | 6.6 | 6.6 | 4.7 | 6.3 | 6.4 | 5.9 | |
| Quick Ratio | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 | 1.4 | 0.9 | 6.3 | 4.5 | 1.8 | 1.4 | 0.2 |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.2 | 0.1 | · | 0.1 | · | · | 0.2 | |
| Inventory Turnover | 0.2 | 0.2 | 0.2 | 0.4 | · | 0.3 | 0.3 | 3.2 | · | · | · | · |
Tasas de Crecimiento 4
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 48.0% | 36.1% | 88.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 56.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -24.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -25.1% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $36M | $27M | $14M | $0 | $0 | $118M | $94M | $43M | $70M | $59M | $65M | |
| Net Income TTM | $-413M | $674M | $-352M | $-232M | $1.60B | $-327M | $-411M | $-346M | $-315M | $-198M | $-118M | $-54M | |
| Market Cap | $1.59B | $1.88B | $1.25B | $1.55B | $1.79B | $3.00B | $3.27B | $2.68B | $2.79B | $1.76B | $2.45B | $4.16B | |
| P/E | -3.8 | 2.8 | -3.5 | -6.6 | 1.2 | -9.1 | -7.0 | · | · | · | · | -70.5 | |
| P/S | 29.4 | 51.5 | 46.4 | 108.5 | · | · | 27.7 | 28.4 | 64.9 | 25.2 | 41.4 | 63.6 | |
| P/B | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | 5.1 | 3.9 | 7.4 | 4.9 | 7.1 | 9.8 | |
| P / Tangible Book | 1.3 | 1.2 | 1.5 | 1.4 | 1.4 | 7.5 | · | · | · | · | · | · | |
| P / Cash Flow | -4.3 | -4.8 | -4.2 | -5.0 | -4.4 | -10.3 | -8.8 | -8.8 | -9.8 | 45.7 | -31.8 | -70.0 | |
| P / FCF | -4.2 | -4.8 | -4.2 | -4.9 | -4.3 | -9.8 | -8.5 | -8.6 | -9.6 | 61.5 | -25.2 | -67.5 | |
| Earnings Yield | -26.2% | 35.4% | -28.4% | -15.1% | 80.8% | -10.9% | -14.4% | · | · | · | · | -1.4% |
Estado de resultados 15
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $21M | $20M | $13M | $12M | $9M | $11M | $9M | $9M | $8M | $7M | $7M | $7M | $6M | $4M | $4M | |
| Cost of Revenue | $3M | $1M | $2M | $2M | $2M | $1M | $1M | $783.0K | $1M | $627.0K | $586.0K | $633.0K | $1M | $554.0K | $413.0K | $517.0K | |
| R&D Expense | $101M | $81M | $88M | $87M | $92M | $73M | $83M | $72M | $77M | $69M | $77M | $82M | $69M | $67M | $70M | $65M | |
| SG&A Expense | $52M | $48M | $52M | $41M | $46M | $42M | $52M | $39M | $36M | $31M | $35M | $26M | $30M | $28M | $33M | $29M | |
| Operating Expenses | $155M | $131M | $142M | $130M | $140M | $115M | $136M | $112M | $114M | $100M | $113M | $108M | $100M | $96M | $103M | $95M | |
| Operating Income | $-111M | $-110M | $-122M | $-117M | $-127M | $-107M | $-125M | $-103M | $-106M | $-92M | $-106M | $-101M | $-94M | $-91M | $-99M | $-91M | |
| Other Non-op | $119.0K | $119.0K | $113.0K | $67.0K | $523.0K | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | |
| Pretax Income | · | · | $-109M | $-103M | · | · | $-105M | $1.00B | · | · | $-96M | $-91M | · | · | · | · | |
| Income Tax | · | · | $-1M | $0 | · | · | $-9M | $53M | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Income | $-101M | $-99M | $-108M | $-103M | $-112M | $-89M | $-97M | $948M | $-96M | $-82M | $-96M | $-91M | $-84M | $-81M | $37M | $-82M | |
| EPS (Basic) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.65 | $16.65 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| EPS (Diluted) | $-1.69 | $-1.69 | $-1.86 | $-1.78 | $-1.93 | $-1.55 | $-1.44 | $16.22 | $-1.69 | $-1.45 | $-1.71 | $-1.64 | $-1.51 | $-1.47 | $0.68 | $-1.49 | |
| Shares (Basic) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,318,009 | 56,939,403 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| Shares (Diluted) | 59,488,871 | 58,782,241 | -115,559,044 | 58,139,277 | 57,932,576 | 57,459,195 | -113,729,562 | 58,432,796 | 56,802,546 | 56,383,475 | -111,021,896 | 55,803,663 | 55,604,330 | 55,265,390 | -109,410,291 | 54,844,579 | |
| EBITDA | $-111M | $-110M | · | $-117M | $-127M | $-107M | · | $-103M | $-106M | $-92M | · | $-101M | $-94M | $-91M | · | $-91M |
Balance general 20
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100M | $114M | $89M | $93M | $81M | $79M | $76M | $254M | $85M | $119M | · | $64M | $85M | $104M | · | $122M | |
| Inventory | $36M | $35M | $33M | $32M | $31M | $30M | $28M | $26M | $24M | $23M | · | $17M | $16M | $11M | · | $5M | |
| Prepaid Expense | $46M | $47M | $44M | $43M | $45M | $42M | $40M | $40M | $35M | $39M | · | $38M | $37M | $39M | · | $46M | |
| Current Assets | $718M | $835M | $942M | $1.03B | $1.02B | $969M | $966M | $1.07B | $632M | $664M | · | $704M | $757M | $792M | · | $785M | |
| PP&E (Net) | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $13M | $14M | · | $17M | $20M | $21M | · | $25M | |
| PP&E (Gross) | · | · | $71M | · | · | · | $68M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $60M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $10M | $4M | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | · | $4M | $4M | $4M | · | $4M | |
| Total Assets | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Accounts Payable | $16M | $14M | $18M | $20M | $18M | $14M | $17M | $17M | $10M | $11M | · | $13M | $12M | $9M | · | $10M | |
| Accrued Liabilities | $35M | $26M | $45M | $37M | $35M | $21M | $47M | $33M | $37M | $25M | · | $30M | $29M | $22M | · | $30M | |
| Current Liabilities | $70M | $59M | $82M | $75M | $70M | $52M | $81M | $119M | $63M | $52M | · | $58M | $55M | $45M | · | $54M | |
| Capital Leases | $12M | $17M | $22M | $27M | $31M | $36M | $40M | $45M | $49M | $53M | · | $61M | $65M | $68M | · | $75M | |
| Other Non-current Liabilities | $240.0K | $90.0K | $90.0K | $90.0K | $101.0K | $880.0K | $880.0K | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Total Liabilities | $82M | $76M | $104M | $101M | $102M | $89M | $122M | $165M | $113M | $106M | · | $120M | $121M | $115M | · | $130M | |
| Retained Earnings | $-762M | $-661M | $-562M | $-454M | $-350M | $-238M | $-149M | $-52M | $-1.00B | $-904M | · | $-727M | $-635M | $-552M | · | $-507M | |
| Treasury Stock | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | $802M | · | $802M | $802M | $802M | · | $802M | |
| Stockholders' Equity | $1.03B | $1.11B | $1.19B | $1.28B | $1.37B | $1.47B | $1.54B | $1.63B | $661M | $744M | $811M | $887M | $964M | $1.04B | $1.10B | $1.05B | |
| Liabilities + Equity | $1.11B | $1.18B | $1.30B | $1.39B | $1.47B | $1.56B | $1.66B | $1.79B | $773M | $850M | · | $1.01B | $1.09B | $1.15B | · | $1.18B | |
| Shares Outstanding | 59,604,830 | 59,341,338 | 58,448,592 | 58,279,876 | 58,038,545 | 57,886,781 | 57,156,285 | 57,021,543 | 56,875,079 | 56,751,511 | 72,161,489 | 55,883,973 | 55,734,775 | 55,541,367 | 71,256,118 | 54,894,031 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $16M | $16M | $14M | $12M | $15M | $11M | $11M | $11M | $12M | $9M | $14M | $9M | $12M | $10M | $11M | $11M | |
| Operating Cash Flow | $-57M | $-119M | $-96M | $-88M | $-77M | $-111M | $-133M | $-84M | $-73M | $-100M | $-72M | $-62M | $-67M | $-95M | $-66M | $-71M | |
| CapEx | $1M | $769.0K | $1M | $2M | $875.0K | $766.0K | $967.0K | $419.0K | $158.0K | $141.0K | $234.0K | $369.0K | $-3.0K | $399.0K | $113.0K | $38.0K | |
| Investing Cash Flow | $40M | $141M | $90M | $96M | $79M | $113M | $-49M | $251M | $37M | $125M | $96M | $39M | $47M | $58M | $83M | $104M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $3M | $2M | $3M | $4M | $65.0K | $2M | $5M | $3M | $1M | $6M | $847.0K | $2M | $237.0K | $2M | $22.0K | $1M | |
| Net Change in Cash | $-14M | $24M | $-4M | $12M | $2M | $3M | $-177M | $169M | $-34M | $31M | $24M | $-20M | $-19M | $-35M | $17M | $34M | |
| Taxes Paid | $70.0K | $4.0K | $-940.0K | $65.0K | $1M | $188.0K | $44M | $-34.0K | $-78.0K | $-525.0K | $-17.0K | $785.0K | $801.0K | $0 | · | $98.0K | |
| Free Cash Flow | · | $-120M | · | · | · | $-112M | · | · | · | $-100M | · | · | · | $-96M | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| Net Margin | -225.1% | -477.7% | · | -803.0% | -899.4% | -1023.2% | · | 10574.7% | -1115.7% | -995.8% | · | -1234.3% | -1248.6% | -1444.4% | · | -2325.0% | |
| Pretax Margin | · | · | · | -803.0% | · | · | · | 11167.3% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -247.1% | -530.3% | · | -907.4% | -1020.1% | -1222.0% | · | -1146.9% | -1228.3% | -1124.3% | · | -1363.7% | -1396.0% | -1615.5% | · | -2590.7% | |
| ROA | -7.8% | -7.2% | · | -6.5% | -10.0% | -7.4% | · | 67.7% | -10.3% | -8.2% | · | -8.3% | -7.2% | -6.5% | · | -6.0% | |
| ROE | -8.4% | -7.7% | · | -7.1% | -11.0% | -8.1% | · | 75.4% | -11.8% | -9.2% | · | -9.4% | -8.0% | -7.2% | · | -6.7% | |
| ROIC | · | · | · | -9.1% | · | · | · | -6.0% | · | · | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.2 | 14.2 | · | 13.8 | 14.5 | 18.5 | · | 9.0 | 10.1 | 12.8 | · | 12.1 | 13.7 | 17.5 | · | 14.6 | |
| Quick Ratio | 1.4 | 1.9 | · | 1.2 | 1.1 | 1.5 | · | 2.1 | 1.3 | 2.3 | · | 1.1 | 1.5 | 2.3 | · | 2.3 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $91M | $55M | · | $43M | $39M | $34M | · | $33M | $31M | $28M | · | $23M | $21M | $16M | · | $10M | |
| Net Income TTM | $-415M | $-404M | · | $643M | $650M | $681M | · | $679M | $-353M | $-338M | · | $-338M | $-338M | $-349M | · | $-357M | |
| Market Cap | $2.21B | $2.01B | · | $2.34B | $1.93B | $1.70B | · | $2.53B | $2.45B | $1.66B | · | $1.38B | $1.58B | $1.28B | · | $1.55B | |
| P/E | -5.2 | -4.9 | · | 3.7 | 3.0 | 2.5 | · | 3.9 | -6.9 | -4.8 | · | -4.1 | -4.6 | -3.6 | · | -4.3 | |
| P/S | 24.4 | 36.6 | · | 54.4 | 49.8 | 49.2 | · | 76.4 | 79.3 | 59.5 | · | 59.5 | 73.7 | 82.1 | · | 156.3 | |
| P/B | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Tangible Book | 2.2 | 1.8 | · | 1.8 | 1.4 | 1.2 | · | 1.6 | 3.7 | 2.2 | · | 1.6 | 1.6 | 1.2 | · | 1.5 | |
| P / Cash Flow | · | -16.9 | · | · | · | -15.2 | · | · | · | -16.6 | · | · | · | -13.4 | · | · | |
| P / FCF | · | -16.8 | · | · | · | -15.1 | · | · | · | -16.6 | · | · | · | -13.3 | · | · | |
| Earnings Yield | -19.1% | -20.5% | · | 27.3% | 33.2% | 39.4% | · | 25.8% | -14.6% | -20.8% | · | -24.7% | -21.7% | -27.8% | · | -23.5% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $54M | $36M | $27M | $14M | $0 |
| Margen Operativo % | -873.9% | -1166.5% | -1459.5% | -2732.1% | — |
| Beneficio neto | $-413M | $674M | $-352M | $-232M | $1.60B |
| EPS Diluido | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 11.5 | 11.9 | 12.3 | 13.3 | 17.8 |
| Ratio Rápido | 1.1 | 0.9 | 1.3 | 2.2 | 3.4 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-377M | $-392M | $-297M | $-314M | $-413M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 264 declarantes · $2.0B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 46 (+12 vs trimestre anterior) | 30 (-3 vs trimestre anterior) | 95 (+17 vs trimestre anterior) | 62 (-27 vs trimestre anterior) | +12.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $219 594 714 | 5 917 400 | 11,17% | Acciones |
| STATE STREET CORP | $131 144 972 | 3 533 633 | 6,67% | Acciones |
| Lynx1 Capital Management LP | $126 505 652 | 3 408 937 | 6,43% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107 552 091 | 2 898 197 | 5,47% | Acciones |
| ARMISTICE CAPITAL, LLC | $104 279 100 | 2 810 000 | 5,30% | Opción de compra |
| VANGUARD CAPITAL MANAGEMENT LLC | $99 523 268 | 2 681 845 | 5,06% | Acciones |
| ARMISTICE CAPITAL, LLC | $89 064 000 | 2 400 000 | 4,53% | Acciones |
| Erste Asset Management GmbH | $81 972 396 | 2 154 900 | 4,17% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $78 332 000 | 2 110 809 | 3,98% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $51 046 957 | 1 375 558 | 2,60% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $50 151 466 | 1 351 093 | 2,55% | Acciones |
| ADAR1 Capital Management, LLC | $47 799 647 | 1 288 053 | 2,43% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $44 225 805 | 1 191 749 | 2,25% | Acciones |
| GOLDMAN SACHS GROUP INC | $36 642 971 | 987 415 | 1,86% | Acciones |
| D. E. Shaw & Co., Inc. | $34 087 168 | 918 544 | 1,73% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $30 078 768 | 810 530 | 1,53% | Acciones |
| Foresite Capital Management VI LLC | $29 131 350 | 785 000 | 1,48% | Acciones |
| CITADEL ADVISORS LLC | $26 154 683 | 704 788 | 1,33% | Acciones |
| Parkman Healthcare Partners LLC | $24 828 297 | 669 046 | 1,26% | Acciones |
| SCS Capital Management LLC | $22 742 864 | 612 850 | 1,16% | Acciones |
| Qube Research & Technologies Ltd | $22 178 346 | 597 638 | 1,13% | Acciones |
| Defilade Capital Management, L.P. | $20 293 529 | 546 848 | 1,03% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19 969 930 | 538 128 | 1,02% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $19 905 062 | 536 380 | 1,01% | Acciones |
| Rock Springs Capital Management LP | $19 763 413 | 532 563 | 1,01% | Acciones |
| Schonfeld Strategic Advisors LLC | $19 300 279 | 520 083 | 0,98% | Acciones |
| Point72 Asset Management, L.P. | $18 790 426 | 506 344 | 0,96% | Acciones |
| JANE STREET GROUP, LLC | $18 280 312 | 492 598 | 0,93% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $14 690 661 | 395 868 | 0,75% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $13 876 579 | 373 931 | 0,71% | Acciones |
| KENNEDY CAPITAL MANAGEMENT LLC | $13 850 565 | 373 230 | 0,70% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $13 342 901 | 359 550 | 0,68% | Acciones |
| Squarepoint Ops LLC | $11 917 431 | 321 138 | 0,61% | Acciones |
| JPMORGAN CHASE & CO | $11 853 074 | 309 008 | 0,60% | Acciones |
| Ensign Peak Advisors, Inc | $11 045 049 | 297 630 | 0,56% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $9 996 803 | 269 383 | 0,51% | Acciones |
| ALGERT GLOBAL LLC | $9 203 540 | 248 007 | 0,47% | Acciones |
| JANE STREET GROUP, LLC | $7 974 939 | 214 900 | 0,41% | Opción de venta |
| Palo Alto Investors LP | $7 926 733 | 213 601 | 0,40% | Acciones |
| Tetragon Partners GP Ltd | $7 629 037 | 205 579 | 0,39% | Acciones |
| AXA Investment Managers S.A. | $7 131 875 | 177 675 | 0,36% | Acciones |
| Cutter Capital Management, LP | $6 895 755 | 235 350 | 0,35% | Acciones |
| BlackRock, Inc. | $6 545 388 | 176 378 | 0,33% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 334 677 | 170 700 | 0,32% | Opción de compra |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $6 306 139 | 169 931 | 0,32% | Acciones |
| FIRST TRUST ADVISORS LP | $6 144 933 | 165 587 | 0,31% | Acciones |
| Ishara Investments LP | $6 086 040 | 164 000 | 0,31% | Acciones |
| GROUP ONE TRADING LLC | $5 640 497 | 151 994 | 0,29% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $5 562 269 | 149 886 | 0,28% | Acciones |
| BANK OF AMERICA CORP /DE/ | $5 505 083 | 148 345 | 0,28% | Acciones |
| MARSHALL WACE, LLP | $5 150 868 | 138 800 | 0,26% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 080 359 | 136 900 | 0,26% | Opción de venta |
| AMERICAN CENTURY COMPANIES INC | $4 991 740 | 134 512 | 0,25% | Acciones |
| Man Group plc | $4 617 931 | 124 439 | 0,23% | Acciones |
| ArrowMark Colorado Holdings LLC | $4 368 367 | 117 714 | 0,22% | Acciones |
| Pictet Asset Management Holding SA | $4 247 606 | 111 861 | 0,22% | Acciones |
| Swiss National Bank | $4 143 703 | 111 660 | 0,21% | Acciones |
| CAPITAL FUND MANAGEMENT S.A. | $3 862 408 | 104 080 | 0,20% | Acciones |
| Assenagon Asset Management S.A. | $3 857 770 | 103 955 | 0,20% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3 700 831 | 99 726 | 0,19% | Acciones |
| Knott David M Jr | $3 527 602 | 95 058 | 0,18% | Acciones |
| Trexquant Investment LP | $3 471 232 | 93 539 | 0,18% | Acciones |
| CITADEL ADVISORS LLC | $3 402 987 | 91 700 | 0,17% | Opción de compra |
| Jain Global LLC | $3 401 020 | 91 647 | 0,17% | Acciones |
| Caligan Partners LP | $3 339 900 | 90 000 | 0,17% | Opción de compra |
| CITADEL ADVISORS LLC | $3 295 368 | 88 800 | 0,17% | Opción de venta |
| CITIGROUP INC | $3 182 331 | 85 754 | 0,16% | Acciones |
| RHUMBLINE ADVISERS | $2 948 045 | 79 441 | 0,15% | Acciones |
| Bank of New York Mellon Corp | $2 916 846 | 78 600 | 0,15% | Acciones |
| Campbell & CO Investment Adviser LLC | $2 712 555 | 73 095 | 0,14% | Acciones |
| Exome Asset Management LLC | $2 616 255 | 70 500 | 0,13% | Acciones |
| Edgestream Partners, L.P. | $2 604 936 | 70 195 | 0,13% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $2 441 059 | 65 779 | 0,12% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2 319 520 | 68 564 | 0,12% | Acciones |
| TWO SIGMA ADVISERS, LP | $2 319 144 | 85 200 | 0,12% | Acciones |
| ALPS ADVISORS INC | $2 228 789 | 60 059 | 0,11% | Acciones |
| Seven Fleet Capital Management LP | $2 111 559 | 56 900 | 0,11% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $2 092 859 | 61 864 | 0,11% | Acciones |
| Rafferty Asset Management, LLC | $2 062 574 | 55 580 | 0,10% | Acciones |
| Engineers Gate Manager LP | $2 000 674 | 53 912 | 0,10% | Acciones |
| WELLS FARGO & COMPANY/MN | $1 935 843 | 52 165 | 0,10% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 931 576 | 52 050 | 0,10% | Acciones |
| XTX Topco Ltd | $1 869 082 | 50 366 | 0,10% | Acciones |
| Caption Management, LLC | $1 855 500 | 50 000 | 0,09% | Opción de compra |
| Tetragon Partners GP Ltd | $1 855 500 | 50 000 | 0,09% | Opción de compra |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1 846 742 | 49 764 | 0,09% | Acciones |
| BARCLAYS PLC | $1 725 651 | 46 501 | 0,09% | Acciones |
| Quantinno Capital Management LP | $1 614 805 | 43 514 | 0,08% | Acciones |
| MARTINGALE ASSET MANAGEMENT L P | $1 596 064 | 43 009 | 0,08% | Acciones |
| IEQ CAPITAL, LLC | $1 499 392 | 40 404 | 0,08% | Acciones |
| Kodai Capital Management LP | $1 485 276 | 50 692 | 0,08% | Acciones |
| Virtus Investment Advisers, LLC | $1 464 843 | 39 473 | 0,07% | Acciones |
| Caption Management, LLC | $1 456 530 | 39 249 | 0,07% | Acciones |
| JANE STREET GROUP, LLC | $1 451 001 | 39 100 | 0,07% | Opción de compra |
| FMR LLC | $1 446 325 | 38 974 | 0,07% | Acciones |
| Aquatic Capital Management LLC | $1 433 448 | 38 627 | 0,07% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1 400 049 | 37 727 | 0,07% | Acciones |
| VANGUARD GROUP INC | $1 308 928 | 48 087 | 0,07% | Acciones |
| EDGEWOOD MANAGEMENT LLC | $1 298 850 | 35 000 | 0,07% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1 298 776 | 34 998 | 0,07% | Acciones |
Informantes de la empresa 33 insiders · 12 directivos · 19 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Brian Goff | Chief Executive Officer | 18 de junio de 2026 A | — | 0 | 0 | $0 |
| Cecilia Jones | Chief Financial Officer | 18 de junio de 2026 A | — | 0 | 0 | $0 |
| Andrew Hirsch | Chief Financial Officer | 22 de abril de 2019 A | 12 374 | 0 | 0 | $0 |
| John Duncan Higgons | Chief Operating Officer | 4 de enero de 2016 M | 120 834 | 0 | 0 | $0 |
| Krishnan Viswanadhan | Chief Strategy and Operations | 18 de junio de 2026 A | — | 0 | 0 | $0 |
| Tsveta Milanova | Chief Commercial Officer | 18 de junio de 2026 A | — | 0 | 0 | $0 |
| James William Burns | Chief Legal Officer | 18 de junio de 2026 A | — | 0 | 0 | $0 |
| Scott Biller | Chief Scientific Officer | 5 de abril de 2019 M | 26 511 | 0 | 0 | $0 |
| Christopher Bowden | Chief Medical Officer | 1 de abril de 2019 M | 7 238 | 0 | 0 | $0 |
| Steven L. Hoerter | Chief Commercial Officer | 4 de marzo de 2019 M | 10 941 | 0 | 0 | $0 |
| Carman Alenson | Principal Accounting Officer | 22 de febrero de 2019 A | 2 796 | 0 | 0 | $0 |
| Glenn Goddard | Senior Vice President, Finance | 16 de febrero de 2016 A | 0 | 0 | 0 | $0 |
| Adams Catherine Owen | Consejero | 18 de junio de 2026 A | 10 865 | 0 | 0 | $0 |
| Rahul D. Ballal | Consejero | 18 de junio de 2026 A | 15 230 | 0 | 0 | $0 |
| David Scadden | Consejero | 18 de junio de 2026 A | 20 419 | 0 | 0 | $0 |
| Maykin Ho | Consejero | 18 de junio de 2026 A | 19 848 | 0 | 0 | $0 |
| Cynthia Smith | Consejero | 18 de junio de 2026 A | 15 230 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Consejero | 18 de junio de 2026 A | 154 156 | 0 | 0 | $0 |
| Kaye I Foster-Cheek | Consejero | 18 de junio de 2026 A | 10 284 | 0 | 0 | $0 |
| Jeffrey D Capello | Consejero | 18 de junio de 2026 A | 10 865 | 0 | 0 | $0 |
| Paul J Clancy | Consejero | 31 de mayo de 2019 M | 1 400 | 0 | 0 | $0 |
| Ian T Clark | Consejero | 31 de mayo de 2019 M | 1 400 | 0 | 0 | $0 |
| John Maraganore | Consejero | 31 de mayo de 2019 M | 37 609 | 0 | 0 | $0 |
| David P Schenkein | Consejero | 22 de febrero de 2019 A | 89 503 | 0 | 0 | $0 |
| Lewis Clayton Cantley Jr. | Consejero | 7 de diciembre de 2017 S | 79 515 | 0 | 0 | $0 |
| Robert Nelsen | Consejero | 6 de marzo de 2017 S | 0 | 0 | 0 | $0 |
| Douglas G. Cole | Consejero | 10 de agosto de 2016 J | 2 778 | 0 | 0 | $0 |
| Marc Tessier-Lavigne | Consejero | 21 de junio de 2016 A | 101 009 | 0 | 0 | $0 |
| Perry A Karsen | Consejero | 23 de junio de 2015 A | — | 0 | 0 | $0 |
| Kevin P Starr | Consejero | 19 de febrero de 2015 J | 184 386 | 0 | 0 | $0 |
| Celgene European Investment Co LLC | Propietario del 10% | 16 de diciembre de 2014 P | 1 231 778 | 0 | 0 | $0 |
| Sarah Gheuens | — | 4 de agosto de 2026 S | 54 645 | 0 | 2 | $-1 064 903 |
| Jay T. Backstrom | — | 8 de julio de 2026 M | 1 447 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY, CELGENE CORPORATION, CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC | 5 de abril de 2021 | — | Presentación inicial | — | SEC |
| CELGENE SWITZERLAND LLC, CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 presentaciones | 14 de noviembre de 2019 | — | Presentación inicial | Estructura de capital | SEC |
| CELGENE EUROPEAN INVESTMENT COMPANY LLC, CELGENE ALPINE INVESTMENT CO., LLC, CELGENE CORPORATION ×3 presentaciones | 17 de diciembre de 2014 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 57 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,64% | 34 703 NS | 30 de abril de 2026 | N-PORT |
| SBIO · ALPS ETF Trust | 1,10% | 60 392 NS | 31 de mayo de 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 0,77% | 43 269 NS | 30 de abril de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,60% | 110 585 NS | 30 de abril de 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,54% | 3 805 SH | 8 de agosto de 2026 | Diario |
| AGNG · Global X Funds | 0,28% | 7 695 NS | 31 de mayo de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,27% | 101 599 NS | 30 de abril de 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,19% | 17 290 SH | 8 de agosto de 2026 | Diario |
| IBB · iShares Trust | 0,14% | 408 719 SH | 8 de agosto de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 3 239 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 48 730 SH | 8 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,13% | 113 617 SH | 8 de agosto de 2026 | Diario |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,12% | 109 727 NS | 31 de mayo de 2026 | N-PORT |
| IWN · iShares Trust | 0,11% | 515 162 SH | 8 de agosto de 2026 | Diario |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,09% | 40 934 NS | 30 de abril de 2026 | N-PORT |
| BIB · ProShares Trust | 0,09% | 2 166 NS | 31 de mayo de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,08% | 22 172 NS | 30 de abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 340 226 SH | 8 de agosto de 2026 | Diario |
| VBK · VANGUARD INDEX FUNDS | 0,06% | 788 655 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,06% | 1 508 427 SH | 8 de agosto de 2026 | Diario |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 9 472 NS | 30 de abril de 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 48 207 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,05% | 24 449 NS | 30 de abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,04% | 2 658 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 193 306 NS | 30 de abril de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 280 734 NS | 31 de mayo de 2026 | N-PORT |
| ISCG · iShares Trust | 0,03% | 10 195 SH | 8 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,03% | 1 364 364 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,03% | 167 169 SH | 8 de agosto de 2026 | Diario |
| ISCB · iShares Trust | 0,03% | 2 463 SH | 8 de agosto de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 25 231 NS | 30 de abril de 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2 079 NS | 31 de mayo de 2026 | N-PORT |
| ISCV · iShares Trust | 0,02% | 5 020 SH | 8 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 683 802 SH | 8 de agosto de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,02% | 2 762 NS | 30 de abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,02% | 2 105 NS | 31 de mayo de 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,02% | 5 903 NS | 31 de mayo de 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 3 329 SH | 8 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 3 639 SH | 8 de agosto de 2026 | Diario |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 2 328 NS | 31 de mayo de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 136 570 NS | 30 de abril de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 8 867 NS | 30 de abril de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 53 NS | 31 de mayo de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 25 095 NS | 31 de mayo de 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 30 958 SH | 8 de agosto de 2026 | Diario |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,01% | 1 068 NS | 31 de mayo de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 4 329 NS | 30 de abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 17 627 NS | 30 de abril de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 19 324 NS | 30 de abril de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 16 536 SH | 8 de agosto de 2026 | Diario |